TLIK — Arzneiwerk VIDA AG Income Statement

0.000.00%

Last trade - 00:00

TelecomsHighly SpeculativeMicro CapValue Trap

Annual income statement for Arzneiwerk VIDA AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	GAS	IFRS	IFRS	IFRS	GAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2.82	2.36	73.4	59.3	0.207
Cost of Revenue
Gross Profit	2.3	1.86	3.14	3.33	0.207
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1.92	2.58	91	61.7	0.809
Operating Profit	0.902	-0.223	-17.7	-2.42	-0.602
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.888	-0.245	-18	-3.02	-0.835
Provision for Income Taxes
Net Income After Taxes	0.825	-0.245	-16.9	-2.88	-0.836
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	0.825	-0.245	-16.6	-2.88	-0.836
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	0.825	-0.245	-16.6	-2.88	-0.836
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.189	-0.055	-1.11	-0.462	-0.134
Dividends per Share